EXPLORE!

CDC Releases New Pneumococcal Vaccine Recommendations for Adults

  638 Views

#Hospital Medicine  #Infectious Diseases  #Pathology and Lab Medicine  #Pharmacist  #Public Health  #Pulmonary Medicine 

eMediNexus    02 February 2022

The US CDC has issued updated pneumococcal vaccine recommendations for adults, calling for the use of two recently approved vaccines in a more streamlined manner, in order to avert the complexities of age and patient conditions.

The recommendations urge the use of the 15-valent pneumococcal conjugate vaccine (PCV15) or the 20-valent PCV. The recommendations are applicable to PCV-naive adults in the United States, either 65 years of age or older, or those who are 19-64 years of age with underlying medical conditions like diabetes, chronic heart or liver disease, or HIV, and have not received a PCV earlier or their prior vaccination history is not known. It has also been stated that if PCV15 vaccine is used, a dose of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) should be given, after at least 1 year… (Medscape)

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.